Colonoscopy delivery of RBX2660 shows promise for recurrent c. diff
NCT ID NCT05831189
First seen Jan 10, 2026 · Last updated May 16, 2026 · Updated 21 times
Summary
This study tested whether RBX2660 (REBYOTA), a treatment for recurrent Clostridioides difficile infection, can be safely and effectively given via colonoscopy instead of the usual method. 41 adults with at least one recurrence of C. diff took part. The main goals were to check for side effects and see if the treatment prevented another infection within 8 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLOSTRIDIUM DIFFICILE INFECTION RECURRENCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ferring Investigational Site
North Little Rock, Arkansas, 72117, United States
-
Ferring Investigational Site
Camarillo, California, 93012, United States
-
Ferring Investigational Site
Hamden, Connecticut, 06518, United States
-
Ferring Investigational Site
Idaho Falls, Idaho, 83404, United States
-
Ferring Investigational Site
Gurnee, Illinois, 60031, United States
-
Ferring Investigational Site
Shreveport, Louisiana, 71105, United States
-
Ferring Investigational Site
Plymouth, Minnesota, 55446, United States
-
Ferring Investigational Site
Rochester, Minnesota, 55905, United States
-
Ferring Investigational Site
Cleveland, Ohio, 44195, United States
-
Ferring Investigational Site
Oklahoma City, Oklahoma, 73102, United States
-
Ferring Investigational Site
Burke, Virginia, 22015, United States
-
Ferring Investigational Site
Madison, Wisconsin, 53705, United States
Conditions
Explore the condition pages connected to this study.